Evaluation of a who-validated serotype-specific serological assay for the diagnosis of pneumococcal etiology in children with community-acquired pneumonia

Pediatric Infectious Disease Journal

Volumn 32, Issue 7, 2013, Pages 277-284

  Tuerlinckx, David ^a   Smet, Julie ^b,c   De Schutter, Iris ^d   Jamart, Jacques ^a   Vergison, Anne ^e   Raes, Marc ^f   Smeesters, Pierre R ^c   Verhaegen, Jan ^g   Surmont, Filip ^h   Malfroot, Anne ^d   Mascart, Francoise ^b,c  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^e HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^f JESSA HOSPITAL   (Belgium)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h PFIZER INC   (United States)

Author keywords

Children; Community acquired pneumonia; Etiology; Serology; Streptococcus pneumoniae

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADOLESCENT; ARTICLE; BLOOD CULTURE; CHILD; CHILDHOOD DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; OBSERVATIONAL STUDY; PLEURA FLUID; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SEROLOGY; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ANTIBODIES, BACTERIAL; BELGIUM; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INFANT; MALE; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; SEROLOGIC TESTS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84883254381     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31828c363f     Document Type: Article

References (33)

1. Obaro SK, Madhi SA. Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining? Lancet Infect Dis. 2006;6:150-161
2. Klugman KP, Madhi SA, Albrich WC. Novel approaches to the identification of Streptococcus pneumoniae as the cause of community-acquired pneumonia. Clin Infect Dis. 2008;47(suppl 3):S202-S206
3. Korppi M, Leinonen M, Ruuskanen O. Pneumococcal serology in children’s respiratory infections. Eur J Clin Microbiol Infect Dis. 2008;27:167-175
4. World Health Organization. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series (927, Annex 2). 2005 Geneva, Switzerland World Health Organization:64-98
5. Concepcion NF, Frasch CE. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 2001;8:266-272
6. Cherian T, Mulholland EK, Carlin JB, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83:353-359
7. Vergison A, Tuerlinckx D, Verhaegen J, et al. Belgian Invasive Pneumococcal Disease Study Group. Epidemiologic features of invasive pneumococcal disease in Belgian children: passive surveillance is not enough. Pediatrics. 2006;118:e801-e809
8. Hanquet G, Lernout T, Vergison A, et al. Belgian IPD Scientific Committee. Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges. Vaccine. 2011;29:2856-2864
9. Michelow IC, Lozano J, Olsen K, et al. Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection. Clin Infect Dis. 2002;34:E1-11
10. Forgie IM, O’Neill KP, Lloyd-Evans N, et al. Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. Pediatr Infect Dis J. 1991;10:42-47
11. Torzillo P, Dixon J, Manning K, et al. Etiology of acute lower respiratory tract infection in Central Australian Aboriginal children. Pediatr Infect Dis J. 1999;18:714-721
12. Simell B, Kilpi TM, Käyhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J Infect Dis. 2002;186:1106-1114
13. Mascart-Lemone F, Gérard M, Libin M, et al. Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine. J Infect Dis. 1995;172:1253-1260
14. Johnson S, Opstad NL, Douglas JM Jr, et al. Prolonged and preferential production of polymeric immunoglobulin A in response to Streptococcus pneumoniae capsular polysaccharides. Infect Immun. 1996;64:4339-4344
15. Lue C, Tarkowski A, Mestecky J. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J Immunol. 1988;140:3793-3800
16. Claesson BA, Trollfors B, Brolin I, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J. 1989;8:856-862
17. Nohynek H, Eskola J, Laine E, et al. The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child. 1991;145:618-622
18. Ruuskanen O, Nohynek H, Ziegler T, et al. Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis. 1992;11:217-223
19. Korppi M, Heiskanen-Kosma T, Jalonen E, et al. Aetiology of community-acquired pneumonia in children treated in hospital. Eur J Pediatr. 1993;152:24-30
20. Korppi M, Leinonen M. Pneumococcal pneumonia in children; new data from circulating immune complexes. Eur J Pediatr. 1997;156:341-342
21. Juvén T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19:293-298
22. Esposito S, Bosis S, Cavagna R, et al. Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2-5 years of age with community-acquired pneumonia. Clin Infect Dis. 2002;35:1345-1352
23. Cevey-Macherel M, Galetto-Lacour A, Gervaix A, et al. Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines. Eur J Pediatr. 2009;168:1429-1436
24. Goldblatt D, Hussain M, Andrews N, et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis. 2005;192:387-393
25. Jourdain S, Drèze PA, Verhaegen J, et al. Carriage-associated Streptocccus pneumoniae serotype 1 in Brussels, Belgium. Pediatr Infect Dis J. 2013;32:86-87
26. Weinberger DM, Harboe ZB, Sanders EA, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis. 2010;51:692-699
27. Jourdain S, Smeesters PR, Denis O, et al. Differences in nasopharyngeal bacterial carriage in preschool children from different socio-economic origins. Clin Microbiol Infect. 2011;17:907-914
28. Blaschke AJ, Heyrend C, Byington CL, et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J. 2011;30:289-294
29. Byington CL, Hulten KG, Ampofo K, et al. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah. J Clin Microbiol. 2010;48:520-525
30. Obando I, Muñoz-Almagro C, Arroyo LA, et al. Pediatric parapneumonic empyema, Spain. Emerging Infect Dis. 2008;14:1390-1397
31. Balmer P, Borrow R, Findlow J, et al. Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine. Clin Vaccine Immunol. 2007;14:1442-1450
32. Esposito S, Droghetti R, Faelli N, et al. Serum concentrations of pneumococcal anticapsular antibodies in children with pneumonia associated with Streptococcus pneumonia infection. Clin Infect Dis. 2003;37:1261-1264
33. Blanchard-Rohner G, Pollard AJ. Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy. Expert Rev Vaccines. 2011;10:673-684